Congo, Democratic Republic of the vs Gabon: Estimated antiretroviral therapy coverage among people living with HIV
Congo, Democratic Republic of the
71.0%
in 2025
Gabon
71.0%
in 2025
Congo, Democratic Republic of the rank
80th
Gabon rank
80th
Estimated antiretroviral therapy coverage among people living with HIV over time
- Congo, Democratic Republic of the
- Gabon
How they compare
Congo, Democratic Republic of the currently reports 71.0% against 71.0% in Gabon, a difference of 0.0%.
The two have swapped places 2 times across 26 shared years of data; in 2000 it was Gabon ahead.
Congo, Democratic Republic of the ranks 80th and Gabon ranks 80th of 143 countries.
Across the 3 decades both report, Congo, Democratic Republic of the averaged higher in 1 and Gabon in 2.
Head to head by decade
| Decade | Congo, Democratic Republic of the | Gabon | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 1.9% | 8.9% | 7.0% | Gabon |
| 2010s | 23.5% | 40.2% | 16.7% | Gabon |
| 2020s | 66.0% | 59.0% | 7.0% | Congo, Democratic Republic of the |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher estimated antiretroviral therapy coverage among people living with hiv, Congo, Democratic Republic of the or Gabon?
- Congo, Democratic Republic of the, at 71.0% against 71.0% in Gabon as of 2025.
- What is the difference in estimated antiretroviral therapy coverage among people living with hiv between Congo, Democratic Republic of the and Gabon?
- 0.0%, with Congo, Democratic Republic of the ahead.
- How many years of comparable data are there for Congo, Democratic Republic of the and Gabon?
- 26 years are reported by both, from 2000 to 2025.
- How do Congo, Democratic Republic of the and Gabon rank globally for estimated antiretroviral therapy coverage among people living with hiv?
- Congo, Democratic Republic of the ranks 80th and Gabon ranks 80th of 143 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Estimated antiretroviral therapy coverage among people living with HIV (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.